BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| December 16, 2014 | 314.79 |
| December 15, 2014 | 314.79 |
| December 12, 2014 | 314.79 |
| December 11, 2014 | 314.79 |
| December 10, 2014 | 314.79 |
| December 09, 2014 | 314.79 |
| December 08, 2014 | 314.79 |
| December 05, 2014 | 314.79 |
| Date | Value |
|---|---|
| December 04, 2014 | 314.79 |
| December 03, 2014 | 314.79 |
| December 02, 2014 | 314.79 |
| December 01, 2014 | 314.79 |
| November 28, 2014 | 314.79 |
| November 26, 2014 | 314.79 |
| November 25, 2014 | 314.79 |
| November 24, 2014 | 314.79 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -- |
| Hansa Biopharma AB | -- |
| BioArctic AB | -- |
| Camurus AB | 132.97 |
PE Ratio Related Metrics
| PS Ratio | 84.18 |
| PEG Ratio | -0.2489 |
| Price to Book Value | 3.109 |
| Price | 4.70 |
| Earnings Yield | -12.57% |
| Market Cap | 309.28M |
| PEGY Ratio | -0.2489 |